Blue Jet Healthcare Limited, originally established as Jet Chemicals Private Limited in 1968, is a specialty pharmaceutical and healthcare ingredient company based in Mumbai. It underwent a series of name changes and structural transformations, becoming a public limited company in 2022. Blue Jet Healthcare specializes in manufacturing pharma intermediates, active pharmaceutical ingredients (APIs), and high-intensity sweeteners, catering to both innovator and generic multinational pharmaceutical companies.
The company has a robust history of innovation, entering the saccharin market in 1970, the X-ray contrast media sector in 2000, and pharma intermediates and APIs in 2002. It operates through a contract development and manufacturing organization (CDMO) model, with significant investments in specialized chemistry capabilities. Over the years, Blue Jet Healthcare has expanded its manufacturing facilities, including recent acquisitions of brownfield and greenfield sites. The company is planning a public offering of 21,683,178 equity shares through an Offer for Sale to raise capital.
